Article thumbnail

The Antioxidant Mechanisms Underlying the Aged Garlic Extract- and S-Allylcysteine-Induced Protection

By Ana L. Colín-González, Ricardo A. Santana, Carlos A. Silva-Islas, Maria E. Chánez-Cárdenas, Abel Santamaría and Perla D. Maldonado

Abstract

Aged garlic extract (AGE) is an odorless garlic preparation containing S-allylcysteine (SAC) as its most abundant compound. A large number of studies have demonstrated the antioxidant activity of AGE and SAC in both in vivo—in diverse experimental animal models associated to oxidative stress—and in vitro conditions—using several methods to scavenge reactive oxygen species or to induce oxidative damage. Derived from these experiments, the protective effects of AGE and SAC have been associated with the prevention or amelioration of oxidative stress. In this work, we reviewed different antioxidant mechanisms (scavenging of free radicals and prooxidant species, induction of antioxidant enzymes, activation of Nrf2 factor, inhibition of prooxidant enzymes, and chelating effects) involved in the protective actions of AGE and SAC, thereby emphasizing their potential use as therapeutic agents. In addition, we highlight the ability of SAC to activate Nrf2 factor—a master regulator of the cellular redox state. Here, we include original data showing the ability of SAC to activate Nrf2 factor in cerebral cortex. Therefore, we conclude that the therapeutic properties of these molecules comprise cellular and molecular mechanisms at different levels

Topics: Review Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:3363007
Provided by: PubMed Central

Suggested articles

Citations

  1. (1981). A new murine model of accelerated senescence,”
  2. (2012). activation, an innovative therapeutic alternative in cerebral ischemia.
  3. (2012). Acute phase proteins in animals,”
  4. (1999). Aged garlic extract attenuates intracellularoxidativestress,”Phytomedicine,v ol.6,no .2,pp .
  5. (2010). Aged garlic extract delays the appearance of infarct area in ac e r e b r a li s c h e m i am o d e l ,a ne ffect likely conditioned by the cellular antioxidant systems,”
  6. (2002). Aged garlic extract therapy for sickle cell anemia patients,”
  7. (2006). Aged Garlic Extract, Research Excerpts from Peer Reviewed Scientific Journals & Scientific Meetings, Wakunaga of America,
  8. (2011). Aguilar-Gonz´ alez et al., “Role of allyl group in the hydroxyl and peroxyl radical scavenging activity of s-allylcysteine,”
  9. (2003). Amyloid β-protein potentiates tunicamycin-induced neuronal death in organotypic hippocampal slice cultures,”
  10. (2006). andK.Ono,“Tetrahydro-β-carbolinederivativesinagedgarlic extract show antioxidant properties,”
  11. (2006). Andr´ es-Mart´ ınez, and A. Santamar´ ıa, “Protective effect of S-allylcysteine on 3-nitropropionic acidinducedlipidperoxidationandmitochondrialdysfunctionin rat brain synaptosomes,”
  12. (1997). Anti-ageing effect of aged garlic extract in the inbred brain atrophy mouse model,”
  13. (2007). Anti-amyloidogenic activity of S-allyl-l-cysteine and its activity to destabilize Alzheimer’s β-amyloidfibrilsinvitro,” NeuroscienceLetters,vol.429,no.2-3,
  14. (2008). Antioxidant and iron-binding properties of curcumin, capsaicin,
  15. (1994). Antioxidant and radical scavenging effects of aged
  16. (1999). Antioxidant effects of fructosyl arginine, a maillard reaction product in aged garlic extract,”
  17. (2002). Antioxidant effects of tetrahydro-β-carboline derivatives identified in aged garlic extract,”
  18. (2001). Antioxidant health effects of aged garlic extract,”
  19. (2003). Antioxidant properties of aged garlic extract: an in vitro study incorporating human low density lipoprotein,”
  20. (2003). Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage,”
  21. (2004). Antioxidative and antiglycative effects of six organosulfur compounds in lowdensity lipoprotein and plasma,”
  22. (1996). Attenuation of rat ischemic brain damage by aged garlic extracts: a possible protecting mechanism as antioxidants,”
  23. (2002). Behavioral characterization of the Tg2576 transgenic model of Alzheimer’
  24. (1997). Beneficial effects of aged garlic extract on learning and memory impairment in the senescence-accelerated mouse,”
  25. (2009). Cardioprotective roles of aged garlic extract, grape seed proanthocyanidin, and hazelnut on doxorubicin-induced cardiotoxicity,”
  26. (2000). Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system,”
  27. (2012). Cognitive and behavioral consequences of impaired immunoregulation in aging,”
  28. (2006). Comparative study of endoplasmic reticulum stress-induced neuronal death in rat cultured hippocampal and cerebellar granule neurons,” Neurochemistry International,v o l .4 9 ,n o .3 ,p p .
  29. (2005). Composition, stability, and bioavailability of garlic products used in a clinical trial,”
  30. (1998). Crofford et al., “Cyclooxygenase in biology and disease,”
  31. (1999). Cu(II) potentiation of Alzheimer aβ neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction,”
  32. (2008). Cytoplasmic calcium mediates oxidative damage in an excitotoxic/energeticdeficitsynergicmodelinrats,”European
  33. (1999). Daily supplementation with aged garlic extract, but not raw garlic, protects low density lipoprotein against in vitro oxidation,”
  34. (2006). Dietary S-allyl-L-cysteine reducesmortalitywithdecreased incidence of stroke and behavioral changes in stroke-prone spontaneously hypertensive rats,”
  35. (2002). Dietary supplementation with aged garlic extract reduces plasma and urine concentrations of 8-iso-prostaglandin F2α in smoking and nonsmoking men and women,”
  36. (2001). Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine,”
  37. (2006). Effe cto fa g e dga rl i ce x tra cto nA P Pp r o c e s s -ingandtauphosphorylationinAlzheimer’stransgenicmodel
  38. (1991). Effect on active oxygen speciesofalliinandalliumsativum(garlic)powder,”Research
  39. (2004). Effects of garlic extract consumption on plasma and erythrocyte antioxidant parameters in atherosclerotic patients,”
  40. (2011). El-Bach´ a, “Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives,” Oxidative Medicine and Cellular Longevity,
  41. (2010). Elinos-Calder´ o n ,Y .R o b l e d o - A r r a t i a ,V .P .D .L aC r u z et al., “Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine,”
  42. (2009). ER stress in Alzheimer’s disease: a novel neuronal trigger for inflammation and Alzheimer’s pathology,”
  43. (2004). Five cysteine-containing compounds have antioxidative activity in Balb/cA mice,”
  44. (1998). Functional relationship between age-related immunodeficiency and learning deterioration,”
  45. (2001). Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-κ b activation,”
  46. (1994). Garlic compounds protect vascular endothelial cells from hydrogen peroxideinduced oxidant injury,”
  47. (1997). Garlic compounds protect vascular endothelial cells from oxidized low density lipoproteininduced injury,”
  48. (1997). Garlic compounds protect vascular endothelialcells fromoxidant injury,”
  49. (1998). Garlic inhibits free radical generation and augments antioxidant enzyme activity in vascular endothelial cells,”
  50. (1998). Garlic: a review of its medicinal effects and indicated active compounds,”
  51. (2004). Glutamatemediated excitotoxicity and neurodegeneration
  52. (2006). Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders,”
  53. (2008). H.S.Chun,J.M.Kim,E.H.Choi,andN.Chang,“Neuroprotective effectsofseveralKoreanmedicinalplantstraditionally used for stroke remedy,”
  54. (2001). Historical perspective on garlic and cardiovascular disease,”
  55. (1996). History, folk medicine, and legendary uses of garlic,” in Garlic: The Science and Therapeutic Application of Allium Sativum L and Related
  56. (1979). Hypertension and acute focal cerebral ischemia. Infarction and edema after occlusion of a middle cerebral artery in cats,”
  57. (2003). Identification of the NF-E2-related factor2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide
  58. (2010). Immuneinflammatory responses and oxidative stress in Alzheimer’s disease: therapeutic implications,”
  59. (2004). Inhibiting progression of coronary calcification using aged garlic extract in patients receiving statin therapy: a preliminary study,”
  60. (2002). Integration and diversity of the regulatory networkcomposedofMafandCNCfamiliesoftranscription factors,”
  61. (2008). Iron and calcium in the central nervous system: a close relationship in health and sickness,”
  62. (2001). Isolation and characterization of the genes up-regulated in isolated neurons by aged garlic extract
  63. (1994). Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the β-globin locus control region,”
  64. (2003). ı, “Aged garlic extract attenuates gentamicin induced renal damage and oxidative stress in rats,”
  65. (2006). ı, “Role of peroxynitrite anion in different diseases,”
  66. (2008). La Cruz et al., “Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine,”
  67. (2001). m a g a s e ,B .L .P e t e s c h ,H .M a t s u u r a ,S .K a s u g a ,a n d Y. Itakura, “Intake of garlic and its bioactive components,”
  68. (2010). Metals, oxidative stress and neurodegenerative disorders,” MolecularandCellularBiochemistry,vol.345,no.1-2,pp.91– 104,
  69. (2011). Neurodegenerative processes
  70. (2002). Neuroprotective effect of garlic compounds in amyloid-β peptide-induced apoptosis
  71. (2003). Neurotoxicity induced by amyloid β-peptide and ibotenic acid in organotypic hippocampal cultures: protection by S-allyl-Lcysteine, a garlic compound,”
  72. (1997). Neurotrophic activity of organosulfur compounds having a thioallyl group on cultured rat hippocampal neurons,”
  73. (1994). Nishiyama,“Prolongationoflifespanandimprovedlearning in the senescence accelerated mouse produced by aged garlic extract,”
  74. (2007). Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity,”
  75. (2009). Nrf2 protects against airway disorders,”
  76. (1997). Oxidative stress hypothesis in Alzheimer’s disease,”
  77. (2001). Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier,”
  78. (2011). Pathophysiological roles of NADPH oxidase/nox family proteins in the vascular system review and perspective,”
  79. (2011). Pedraza-Chaverri,P.D.Maldonado,andE.Ruiz-S´ anchez,“SAllylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice,”
  80. (2005). Pharmacokinetics and tissue distribution of S-allylcysteine,”
  81. Projections of dementia prevalence and incidence
  82. (2007). r u z ,R .C o r r e a - R o t t e r
  83. (1999). Redox metals andneurodegenerativedisease,”CurrentOpinioninChemical
  84. (2011). Relationship of electrophilic stress to aging,”
  85. (2007). Role of caspase12 in amyloid β-peptide-induced toxicity in organotypic hippocampal slices cultured for long periods,”
  86. (2011). S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocininduced experimental dementia of Alzheimer’s type,”
  87. (1997). S-allyl cysteine inhibits activation of nuclear factor κ Bi nh u m a nTc e l l s ,
  88. (2001). S-allyl cysteine reduces oxidant load in cells involved in the atherogenic process,”
  89. S-allyl cysteine, S-ethyl cysteine, and S-propyl cysteine alleviate β-amyloid, glycative, and oxidative injury in brain of mice treated by D-galactose,”
  90. (2009). S-Allyl L-cysteine diminishes cerebral ischemia-induced mitochondrial dysfunctions in hippocampus,”
  91. (2006). S-Allyl-l-cysteine attenuates cerebral ischemic injury by scavenging peroxynitrite and inhibiting the activity of extracellular signal-regulated kinase,”
  92. (2003). S-allyl-L-cysteine selectively protects cultured rat hippocampal neurons from amyloid β-protein- and tunicamycin-induced neuronal death,”
  93. (1999). S-Allylcysteine attenuates oxidative stress in endothelial cells,”
  94. (2001). S-allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia,”
  95. (2006). S-Allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity, early markers of oxidative stress and mitochondrial dysfunction,”
  96. (2007). S-allylcysteine scavenges singlet oxygen and hypochlorous acid and protects LLC-PK1 cells of potassium dichromate-induced toxicity,” Food and Chemical Toxicology,
  97. (2004). Sallylmercaptocysteine scavenges hydroxyl radical and singlet oxygen in vitro and attenuates gentamicin-induced oxidative andnitrosativestressandrenaldamageinvivo,” BMCClinical Pharmacology,
  98. (1996). Scavenging effect of aged garlic extract and its constituents on active oxygen species,”
  99. (1986). Sickle cell membranes and oxidative damage,”
  100. (2002). Structure and function of xanthine oxidoreductase: where are we now?”
  101. (2003). t o ,Y .K o s u g e ,T .S a k i k u b oe ta l . ,“ P r o t e c t i v ee ffect of Sallyl-L-cysteine, a garlic compound, on amyloid β-proteininducedcelldeathinnervegrowthfactor-differentiatedPC12 cells,”
  102. (2006). The antioxidant properties of garlic compounds: alyl cysteine, alliin, allicin, and allyl disulfide,”
  103. (1985). The chemistry of garlic and onions,”
  104. (2011). The chemopreventive effects of aged garlic extract against cadmium-induced toxicity,”
  105. (2005). The Nrf2-ARE signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders,”
  106. (2004). The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress,”
  107. (2011). The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson’s disease,”
  108. (1996). Therapeutic effects of garlic and its preparations,” in Garlic: The Science and Therapeutic Application of Allium Sativum L and Related
  109. (1996). Trophic effects of aged garlic extract (AGE) and its fractions on primary cultured hippocampal neurons from fetal rat brain,”
  110. (2007). United States life tables,
  111. (1987). Unusual conjugates in biological profiles originating from consumption of onions and garlic,”
  112. (1998). V a n e ,Y .S .B a k h l e ,a n dR .M .B o t t i n g ,“ C y c l o o x y g e n a s e s 1 and 2,” Annual Review of Pharmacology and Toxicology,
  113. (2011). Villeda-Hern´ andez et al., “Aged garlic extract attenuates cerebral damage and cyclooxygenase-2 induction after ischemia and reperfusion in rats,” Plant Foods for Human Nutrition,v o l .6 6 ,n o .4 ,p p .
  114. (2001). y u ,N .I d e ,H .M a t s u u r a ,a n dY .I t a k u r a ,“ N α-(1-deoxyD-fructos-1-yl)-L-arginine, an antioxidant compound ident i fi e di na g e dg a r l i ce x t r a c t ,
  115. (2002). Y.Kodera,A.Suzuki,O.Imadaetal.,“Physical,chemical,and biologicalpropertiesofS-allylcysteine,anaminoacidderived from garlic,”

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.